COMMUNIQUÉS West-GlobeNewswire
-
Cerene® Cryotherapy Announces Know Your Flow Event Series To Empower Women Through Free Menstrual and Perimenopause Education
08/07/2026 -
SRX Global Declares One-Time Cash Dividend
08/07/2026 -
GumiTide Official Announces 2026 In The USA & Canada New Advanced Formula Gumitide Gummies For Weight Loss in Markets
08/07/2026 -
Nordic Ranked No. 1 Overall in Black Book’s 2026 Healthcare IT Consulting and Advisory Services Report
08/07/2026 -
Une première mondiale : le protocole de traitement par cellules souches en une seule séance du KFSH de Djeddah établit une nouvelle référence en matière de sécurité des donneurs et d’efficacité thérapeutique
08/07/2026 -
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
08/07/2026 -
American Physical Therapy Association and Inteleos Activate Partnership with First Joint Educational Program for Musculoskeletal Ultrasound Imaging Standards and Certification
08/07/2026 -
Ultragenyx Releases 2025 Impact Report Emphasizing Commitment to Rare Disease Patients, Innovation, and Global Impact
08/07/2026 -
60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases
08/07/2026 -
Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection
08/07/2026 -
Cannara Biotech Inc. annoncera ses résultats financiers pour le troisième trimestre de l'exercice 2026 le 15 juillet 2026
08/07/2026 -
Families Report Positive Outcomes From Fully Virtual, BCBA-Delivered, Focused Autism Support Program
08/07/2026 -
NOMAD Increases Voyager Fleet Energy Storage by up to 56%, Bringing Eagle and Falcon to 2.025 MWh
08/07/2026 -
Global Alzheimer’s Platform Foundation Announces Strategic Partnership with Taudia for the Transformative Bio-Hermes-002 Study
08/07/2026 -
Tekton Research and Summit Clinical Research Solutions Expand Partnership, Bring MASH Trials to Ohio
08/07/2026 -
Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer’s Association International Conference in London on July 13, 2026
08/07/2026 -
Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform
08/07/2026 -
Polomar Health Services Strengthens Board Leadership to Support Standalone Growth Strategy
08/07/2026 -
International Gastroenterology Expert Working Group Publishes Consensus Framework for Improved Classification of Gastric Function in Patients with Chronic Stomach Conditions
08/07/2026
Pages